Cross-talk of four types of RNA modification writers defines the immune microenvironment in severe asthma
- PMID: 35506887
- DOI: 10.1111/nyas.14782
Cross-talk of four types of RNA modification writers defines the immune microenvironment in severe asthma
Abstract
Adenine modifications, including m6 A, m1 A, APA, and A-to-I modifications, are the most impactful RNA modifications. These modifications are primarily produced by enzymes called writers. The main purpose of this study was to explore the cross-talk and potential roles of these writers in severe asthma. We found 13 RNA writers potentially related to severe asthma and three RNA modification patterns. Cluster 3 showed predominant neutrophil infiltration and C-type lectin receptor signaling; cluster 1 showed predominant innate immune cell infiltration and ubiquitin-proteasome system activation; and cluster 2 did not show obvious immune infiltration characteristics. We found that RNA modification writers modified immune cell-related genes and led to both accumulation of different immune cells in the airways and activation of a series of biological processes, which ultimately leads to severe asthma. TRMT6, WTAP, and TRMT6A were included in a random forest model as predictors. Cromoglicic acid, thioperamide, and fluvastatin were potential drugs for clusters 1, 2, and 3, respectively. We found that cross-talk of RNA modifications is significant in severe asthma, which provides insight into severe asthma pathogenesis and possible treatment avenues.
Keywords: RNA modification pattern; RNA modification writers; epigenetics; immune microenvironment; severe asthma; treatment.
© 2022 New York Academy of Sciences.
References
REFERENCES
-
- Singh, P., Sharma, A., Jha, R., Arora, S., Ahmad, R., Rahmani, A. H., Almatroodi, S A., Dohare, R., & Syed, M. A. (2020). Transcriptomic analysis delineates potential signature genes and miRNAs associated with the pathogenesis of asthma. Science Reports, 10, 13354.
-
- Schoettler, N., & Strek, M. E. (2020). Recent advances in severe asthma: From phenotypes to personalized medicine. Chest, 157, 516-528.
-
- Jones, T. L., Neville, D. M., & Chauhan, A. J. (2018). Diagnosis and treatment of severe asthma: A phenotype-based approach. Clinical Medicine (London), 18(Supp l), s36-s40.
-
- Cote, A., Godbout, K., & Boulet, L. P. (2020). The management of severe asthma in 2020. Biochemical Pharmacology, 179, 114112.
-
- Shrine, N., Portelli, M. A., John, C., Artigas, M. S., Bennett, N., Hall, R., Lewis, J., Henry, A. P., Billington, C. K., Ahmad, A., Packer, R. J., Shaw, D., Pogson, Z. E. K., Fogarty, A., McKeever, T. M., Singapuri, A., Heaney, L. G., Mansur, A. H., Sayers, R. C., …Sayers, I. (2019). Moderate-to-severe asthma in individuals of European ancestry: A genome-wide association study. Lancet Respiratory Medicine, 7, 20-34.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical